期刊文献+

分析PSM-E和PSMA在预测前列腺癌生化复发中的价值 被引量:1

PSM-E and PSMA in prediction of biochemical recurrence of prostate cancer
下载PDF
导出
摘要 目的分析前列腺特异性膜抗原(PSMA)及其新型剪接变异体(PSM-E)在预测前列腺癌患者生化复发上的作用。方法选取行前列腺癌根治术,影像学资料未提示转移而Gleason评分〉7分的局限性前列腺癌患者15例,荧光定量PCR检测PSM-E和PSMA在术前外周血及切出肿瘤组织中的RNA表达,分析外周血及组织中PSM-E和PSMA相对表达的差异。术后随访患者前列腺特异性抗原(PSA)的变化。结果PSM-E和PSMA在前列腺癌组织中表达高于外周血,差异具有统计学意义(P〈0.01)。在前列腺癌组织中,PSM-E的表达明显低于PSMA;在前列腺癌患者的外周血中,PSM-E的表达明显高于PSMA,差异具有统计学意义(P〈0.01)。外周血PSM-E和PSMA表达阳性的患者术后生化复发率为66.7%(8/12),远处转移率为25.0%(3/12),均高于表达阴性的患者(0.O%,0/3),3例远处转移者表现为骨转移。结论在前列腺癌患者中,外周血检测PSM-E与PSMA均能地作为预测前列腺癌生化复发的指标。 Objective To analyze the value of prostate-specific membrane antigen (PSMA) and its new splicing variant (PSM-E) in predicting the biochemical recurrence of prostate cancer. Methods 15 prostate cancer patients without metastasis indicated by imaging data and whose Gleason score 〉7 and undergoing radical prostatectomy were selected. The expressions of PSMA and PSM-E in peripheral blood and prostate cancer tissue were detected by real-time PCR before the operation. The differences of the expressions of PSMA and PSM-E between in peripheral blood and in prostate cancer tissue were analyzed. The changes of prostate specific antigen (PSA) in the patients after surgery were followed up. Results The expressions of PSMA and PSM-E was higher in tissue than in peripheral blood, with statistical differences (P〈0.01). The expression of PSM-E in tissue was statistically lower but in peripheral blood was statistically higher than that of PSMA (P〈0.01). The postoperative biochemical recurrence ratio was 66.7% (8/12) in the patients with positive expressions of PSM-E and PSMA in peripheral blood and the metastasis ratio was 25.0% (3/12). Both of them were higher than in the patients with negative expressions whose ratio was 0.0% (0/3). All the three metastasis patients were bone metastasis. Conclusions Both PSME and PSMA can predict the biochemical recurrence of prostate cancer through peripheral blood.
出处 《国际医药卫生导报》 2015年第15期2104-2107,共4页 International Medicine and Health Guidance News
基金 广东省科技计划项目(20098030801131)
关键词 前列腺特异性膜抗原 微转移 剪接变异体 生化复发 Prostate-specific membrane antigen Micro-metastasis Spliced variant Biochemicalrecurrence
  • 相关文献

参考文献10

  • 1Simsir A, Cal C, Mammadov R, et al. Biochemical recurrence after radical prostatectomy: is the disease or the surgeon to blame?[J].Int Braz J Urol, 2011, 37 ( 3 ) : 328-334.
  • 2鲁欣 任善成 孙颖浩.前列腺癌根治术后生化复发的诊断和治疗.中华泌尿外科杂志,2007,28(12):861-862.
  • 3Graefen M, Karakiewicz PI, Cagiannos I, et al. International validation of a preoperative nomogram for prostate cancer recurrence after radical prostatectomy [J]. J Clin Oncol, 2002, 20 ( 15 ) : 3206-3212.
  • 4Radwan MH, Yan Y, Luly JR, et al. Prostate-Specific Antigen Density Predicts Adverse Pathology and Increased Risk of Biochemical Failure[J]. Urology, 2007, 69 (6) : 1121-1127.
  • 5Kurek R, Nunez G, Tselis N, et aL Prognostic value of combined "triple"-reverse transcription-PCR analysis for prostate-specific antigen, human kallikrein 2, and prostate-specific membrane antigen mRNA in peripheral blood and lymph nodes of prostate cancer patients [J]. Clin CancerRes, 2004, 10 (17) : 5808-5814.
  • 6Cao KY, Mao XP, Wang DH, et al. High expression of PSM-E correlated with tumor grade in prostate cancer: A new alternatively spliced variant of prostate-specific membrane antigen[J]. Prostate, 2007,67( 16 ): 1791-1800.
  • 7Israeli RS, Miller WJ Jr, Su SL, et al.Sensitive nested reverse transcription polymerase chain reaction detection of circulating prostatic tumor cells: comparison of prostate-specific membrane antigen and prostate-specific antigen-based assays[J]. Cancer Res, 1994, 54 ( 24 ) : 6306-6310.
  • 8Grasso YZ, Gupta MK, Levin HS, et aLCombined nested RT-PCR assay for prostate-specific antigen and prostate-specific membrane antigen in prostate cancer patients: correlation with pathological stage[J]. Cancer Res, 1998, 58 (7) : 1456-1459.
  • 9余斌,王禾,武国军,付振红,王栋.巢式RT-PCR检测前列腺癌患者外周血中PSA mRNA和PSM mRNA的比较[J].第四军医大学学报,2002,23(24):2253-2256. 被引量:4
  • 10瞿虎,陈羽,丘少鹏,毛晓鹏,郭胜杰.前列腺特异性膜抗原新型剪接变异体PSM-E在外周血的定量表达[J].中山大学学报(医学科学版),2009,30(3):294-298. 被引量:4

二级参考文献20

  • 1黄伟刚,赖建生,林津,许胜利.健康男性与前列腺疾病患者的血清前列腺特异抗原水平差异[J].新医学,2004,35(9):551-552. 被引量:3
  • 2黄海,黄健,潘秋辉,林天歆,郭正辉,许可慰,江春,韩金利.中国人前列腺特异性膜抗原基因的克隆及鉴定[J].中山大学学报(医学科学版),2005,26(1):84-87. 被引量:10
  • 3陈贤璟,丘少鹏,毛晓鹏,王杜渐,黎明涛.前列腺特异性膜抗原基因片段在酿酒酵母中的诱导表达及意义[J].中山大学学报(医学科学版),2005,26(6):631-634. 被引量:1
  • 4Mhawech-Fauceglia P,Zhang S,Terracciano L,黄文斌(摘译).前列腺特异性膜抗原蛋白在正常和肿瘤组织中的表达及其在前列腺癌诊断中的敏感性和特异性[J].临床与实验病理学杂志,2007,23(3):261-261. 被引量:34
  • 5Guo YL. Benign prostate hyperplasia and prostate carcinoma [M]. 2nded. Bejing: Renmin Weishen Chubanshe (Bejing: People Medical Publishing Company), 1998: 131-138.
  • 6Chang SS, Gaudin PB, Reuter VE, Heston WD. Prostate-specific membrane antigen: Present and future applications [J]. Urology, 2000;55:622-629.
  • 7Bostwick CG, Pacelli A, Blutell. Prostate specific membrane antigen expression in prostatic intraepithelial neoplasia and adenocarcinoma: A study of 184 cases [J]. Cancer, 1998;82:2256-2259.
  • 8Murphy GP, Su S, Jarisch J, Kenny GM. Serum levels of PSMA [J]. Prostate, 2000;42(4):318-319.
  • 9Hara N, Kasahara T, Kawasaki T, Bilim V, Obara K, Takahashi K, Tomita Y. Reverse transcription-polymerase chain reaction detection of prostate-specific antigen, prostate-specific membrane antigen, and prostate stem cell antigen in one milliliter of peripheral blood: Value for the Staging of Prostate Cancer [J]. Clin Cancer Res, 2002;8(6):1794-1799.
  • 10Llanes L, Ferruelo A, Paez A, Gomez JM, Moreno A, Berenguer A. The clinical utility of the prostate specific membrane antigen reverse-transcription/polymerase chain reaction to detect circulating prostate cells: An analysis in healthy men and women [J]. BJU Int, 2002;89(9):882-885.

共引文献7

同被引文献12

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部